Company / Operating Income per Share
Gilead Sciences Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$8.04
FY2025
5-year range
$1.33 / $8.04
FY2021-FY2025
Trend
+503.0%
vs FY2024
Sector context
#8 of 201
Health Care
What the data says
Operating Income per Share changed +503% YoY in FY2025, a notable deviation from the 9-year average annual change of +57%.
Based on SEC 10-K filings.
8.04 in FY2025 with a 5-year CAGR of +20.1%. Top quartile in the Health Care sector.
Remained stable around $8.04 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +35.3%
- 5-Year CAGR
- +20.1%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 201This company $8.04 Sector average -$28.56
▼
+128.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 503.0% year-over-year.
- Ranks #8 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.04 | +503.0% |
| FY2024 | $1.33 | -83.2% |
| FY2023 | $7.95 | +145.0% |
| FY2022 | $3.25 | -5.0% |
| FY2021 | $3.42 | +6.3% |
| FY2020 | $3.22 | -70.8% |
| FY2019 | $11.02 | -18.3% |
| FY2018 | $13.48 | -20.4% |
| FY2017 | $16.94 | +57.8% |
| FY2016 | $10.73 | -27.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026